药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pergolide
Rabies virus inactivated antigen, B
The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Bosutinib.
Pergolide
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Bosutinib.
Pergolide
TG4010
The therapeutic efficacy of TG4010 can be decreased when used in combination with Bosutinib.
Pergolide
Vitespen
The therapeutic efficacy of Vitespen can be decreased when used in combination with Bosutinib.
Pergolide
GI-5005
The therapeutic efficacy of GI-5005 can be decreased when used in combination with Bosutinib.
Pergolide
SRP 299
The therapeutic efficacy of SRP 299 can be decreased when used in combination with Bosutinib.
Pergolide
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Bosutinib.
Pergolide
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Bosutinib.
Pergolide
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Bosutinib.
Pergolide
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Bosutinib.
Pergolide
Fingolimod
Bosutinib may increase the immunosuppressive activities of Fingolimod.
Pergolide
Metamizole
The risk or severity of myelosuppression can be increased when Metamizole is combined with Bosutinib.
Pergolide
(S)-Warfarin
The serum concentration of (S)-Warfarin can be increased when it is combined with Bosutinib.
Pergolide
S,R-Warfarin alcohol
The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Bosutinib.
Pergolide
R,S-Warfarin alcohol
The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Bosutinib.
Pergolide
(R)-warfarin
The serum concentration of (R)-warfarin can be increased when it is combined with Bosutinib.
Pergolide
Niperotidine
Niperotidine can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Lavoltidine
Lavoltidine can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Lafutidine
Lafutidine can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pergolide
Roxatidine acetate
Roxatidine acetate can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.